Stock Quote

Eisai Co.,Ltd. (4523.T) (Tokyo Stock Exchange)
As of  1:00am EST
3,100JPY
Price Change
-40
Percent Change
-1.27%
 
¥3,100
1:00am EST
-1.27%
¥3,140
¥3,130
1,008,900
¥3,170
¥3,090
¥3,810
¥2,620
0.80
875,600

Research Another Stock: Symbol Look-up
FDA warns Shire, Eisai on promotions
Friday, 13 Nov 2009 05:01pm EST 
UPDATE 1-US FDA warns Shire, Eisai on promotions
Friday, 13 Nov 2009 05:01pm EST 
Takeda keeps forecast, drugs outlook still tough
Friday, 30 Oct 2009 01:07am EDT 
TABLE-Eisai <4523.T>-6mth group results
Friday, 30 Oct 2009 12:31am EDT 
 
Name Current Position Compensation
Naito, Haruo Executive President, Chief Executive Officer, Representative Executive Officer, Director --
Matsui, Hideaki Chief Financial Officer, Senior Managing Executive Officer, Rep Executive Officer --
Akada, Yukio Executive Officer, Chairman and GM of Subsidiary --

Profile

Eisai Co., Ltd. is a Japan-based company mainly engaged in the manufacturing and sale of pharmaceutical products. The Company operates in two business segments. The Pharmaceutical segment is engaged in the research, development, manufacturing and sale of drugs for pharmaceutical, over-the-counter... Full Description

Company Address

Eisai Co.,Ltd.
4-6-10 Koishikawa
Bunkyo-ku   TKY   112-8088
P: +813.38173700
F: +813.38113077

Analyst Research

  4523.T Industry
P/E(TTM) -- 3.65
P/S(TTM) -- 0.57
ROI(TTM) -- 1.87
ROE(TTM) -- 2.53
Consensus Recommendation Hold
EPS Est. (Current Period) --
EPS Est. (Current Year) --
Total Revenue $200,311.00M
Net Income $14,710.00M
EPS $51.14